featured
7 vs 28 Days of Albendazole Monotherapy for Single-Lesion Neurocysticercosis in Children
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Child Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children
J. Child Neurol. 2022 Jan 01;37(1)28-34, N Johnson, AG Saini, P Malhi, N Khandelwal, P SinghiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.